Literature DB >> 4084335

Cyclosporine in the treatment of intractable polymyositis.

H S Goei The, P Jacobs, H Houben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4084335     DOI： 10.1002/art.1780281220

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  4 in total

1.  Polymyositis and cyclosporin A.

Authors:  J Alijotas; J Barquinero; J Ordi; M Vilardell
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 2.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  High-dose intravenous human immunoglobulin in polymyositis resistant to treatment.

Authors:  S Jann; S Beretta; M Moggio; L Adobbati; G Pellegrini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.